脆弱性和肝移植资格超出MELD分数:将功能状态纳入候选人选择中
Maha Elsabaawy1, Sameh Afify2, Warda Othman2
1Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Kom, Menoufia, Egypt. maha.ahmed@liver.menofia.edu.eg.
BMC gastroenterology
|October 22, 2025
概括
使用临床虚弱度量表 (CFS) 的虚弱度评估比MELD-Na更准确地预测肝移植资格. 这突显了脆弱性是公平选择患者的关键因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 老年病的医生 老年病的医生
背景情况:
- 末期肝病模型 (MELD) 评分对于肝移植优先考虑至关重要,但不考虑患者的脆弱性.
- 脆弱性是移植资格和患者结果的重要预测因素.
研究的目的:
- 评估虚弱对肝移植资格的影响.
- 将脆弱性评估的预测准确性与MELD-Na得分进行比较.
主要方法:
- 一项针对正在接受移植评估的成年肝硬化患者的前性研究.
- 由一个多学科团队使用临床脆弱度量 (CFS) 评估的脆弱性.
- 计算了MELD分数;移植资格根据机构标准确定.
主要成果:
- 在672名患者中,有76人 (11.3%) 符合移植条件.
- 符合条件的患者比不符合条件的患者 (平均CFS 5.8) 有较低的MELD得分和更好的脆弱状态 (平均CFS 3.2).
- 与MELD (AUC 0.72) 相比,CFS表现出更高的资格预测准确度 (AUC 0.84).
结论:
- 临床虚弱度量表 (CFS) 的评估比MELD-Na.Na.更有效地预测肝移植资格.
- 虚弱是符合条件的实际决定因素,特别是在MELD得分较低的患者中.
- 这些发现支持制定标准化,基于证据的框架,以公平地选择肝移植.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
01:28Kidney Transplant I: Introduction
339
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
339
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
211
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
211
01:24Tissue Transplantation
894
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
894
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
541
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
541